Storage and handling
Other information tamper evident: do not use if carton is open or if printed seal on blister is broken or missing store between 20 to 25°C (68 to 77°F)
Other information tamper evident: do not use if carton is open or if printed seal on blister is broken or missing store between 20 to 25°C (68 to 77°F)
Drug Facts
Active ingredient (in each extended release tablet)
Guaifenesin 600 mg
Purpose
Expectorant
Uses helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Warnings
Do not use
Ask a doctor before use if you have
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
Directions
Other information
Inactive ingredients carbomer homopolymer, hypromellose, microcrystalline cellulose, povidone
Questions? 1-844-243-1241
You may also report side effects to this phone number.
Distributed by:
Little Pharma, Inc.
New York, NY 10023
curist
Mucus Relief
Guaifenesin Extended-Release Tablets 600 mg
Expectorant
12 Hour
Relieves Chest Congestion
Thins and Loosens Mucus
30 Extended Release Tablets
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 72559-001 | 72559-001-03 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | IACT |
| HYPROMELLOSE 2208 (100000 MPA.S) | VM7F0B23ZI | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| POVIDONE | FZ989GH94E | IACT |
| GUAIFENESIN | 495W7451VQ | ACTIB |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209215-001 | GUAIFENESIN | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | ||
| A209215-002 | GUAIFENESIN | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A209215-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A209215-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A209215-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A209215-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A209215-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A209215-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209215-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209215-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A209215-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A209215-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209215-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209215-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209215-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209215-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209215-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209215-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209215-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209215-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209215-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209215-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209215-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209215-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A209215-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A209215-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209215-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209215-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209215-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209215-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209215-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209215-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A209215-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A209215-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209215-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209215-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A209215-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A209215-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A209215-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A209215-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A209215-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A209215-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2017-09-06 | 74a2ff9319b5… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2632024f-920c-feb0-e063-6394a90ade99 | 8a9b9230-ed87-7a61-e053-2995a90a33ac | 2024-11-05 | Warnings | 8a9b9230-ed87-7a61-e053-2995a90a33ac |
Adverse event summaries are temporarily unavailable. Other product information remains available.